Affluent Medical SA (AFME.PA)
EUR 1.54
(0.99%)
EUR 1.54
(0.99%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -13.34 Million EUR | -13.11% |
| 2022 | -12.33 Million EUR | -8.79% |
| 2021 | -10.88 Million EUR | -3.32% |
| 2020 | -10.47 Million EUR | 19.42% |
| 2019 | -12.55 Million EUR | 0.0% |
| 2017 | -9.96 Million EUR | -45.98% |
| 2016 | -6.93 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.8 Million EUR | -9.5% |
| 2024 Q2 | -3.8 Million EUR | 0.0% |
| 2023 Q4 | -3.47 Million EUR | -5.43% |
| 2023 FY | - EUR | -21.97% |
| 2023 Q1 | -3.19 Million EUR | 49.89% |
| 2023 Q2 | -6.91 Million EUR | -116.01% |
| 2023 Q3 | -3.29 Million EUR | 52.34% |
| 2022 Q4 | -6.38 Million EUR | -114.99% |
| 2022 FY | - EUR | -8.79% |
| 2022 Q3 | -2.96 Million EUR | 56.32% |
| 2022 Q2 | -6.79 Million EUR | -112.7% |
| 2022 Q1 | -3.19 Million EUR | 42.22% |
| 2021 FY | - EUR | -3.32% |
| 2021 Q4 | -5.53 Million EUR | -130.51% |
| 2021 Q3 | -2.39 Million EUR | 57.14% |
| 2021 Q2 | -5.59 Million EUR | -73.37% |
| 2021 Q1 | -3.22 Million EUR | -9.18% |
| 2020 FY | - EUR | 19.42% |
| 2020 Q2 | -2.45 Million EUR | 0.0% |
| 2020 Q1 | -2.45 Million EUR | 0.0% |
| 2020 Q3 | -2.95 Million EUR | -20.59% |
| 2020 Q4 | -2.95 Million EUR | 0.0% |
| 2019 FY | - EUR | 0.0% |
| 2017 FY | - EUR | -45.98% |
| 2016 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bluelinea Société Anonyme | -323.98 EUR | -4118364.103% |
| Carmat SA | -50.45 Million EUR | 73.553% |
| Diagnostic Medical Systems S.A. | -7.05 Million EUR | -89.075% |
| Euromedis Groupe | -4.43 Million EUR | -200.844% |
| Eurobio Scientific Société anonyme | 18.98 Million EUR | 170.278% |
| Ikonisys S.A. | -2.34 Million EUR | -468.386% |
| Implanet S.A. | -5.07 Million EUR | -162.813% |
| Median Technologies SA | -19.58 Million EUR | 31.871% |
| SpineGuard SA | -3.49 Million EUR | -281.575% |
| Theraclion SA | -4.48 Million EUR | -197.354% |
| Euroapi S.A. | -155.39 Million EUR | 91.414% |
| Guerbet SA | 98.83 Million EUR | 113.5% |
| Ion Beam Applications SA | 12.53 Million EUR | 206.488% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 101.282% |
| Sequana Medical NV | -29.13 Million EUR | 54.206% |